Neurogenesis and Neuroinflammation in Dialogue: Mapping Gaps, Modulating Microglia, Rewiring Aging
Open accessThe DOI matches its Crossref record; 394 of the 394 references it cites were found in a registry or an index.
Abstract
Background: Aging brains are shaped by a persistent dialogue between declining neurogenesis and rising neuroinflammation. Neural stem cells progressively lose regenerative capacity, while microglia and astrocytes shift toward maladaptive states that erode synaptic plasticity and cognition. This convergence defines inflammaging, a slow yet relentless process that undermines resilience. However, the field remains hampered by critical gaps: incomplete mapping of microglial heterogeneity, poorly understood epigenetic scars from inflammasome signaling, lack of longitudinal data, unclear niche-specific immune mechanisms, and uncertain cross-species relevance. This review addresses these pressing barriers, aiming to transform fragmented insights into actionable strategies. Summary: I chart how neurogenesis and neuroinflammation operate in continuous dialogue, identify five major knowledge gaps, and evaluate strategies to reprogram this interaction. Approaches include longitudinal imaging, niche-focused immunomodulation, glial subtype reprogramming, brain-penetrant inflammasome inhibitors, and CRISPR-based epigenetic editing. Each strategy is mapped against translational potential, short-term feasibility, and long-term vision, with emphasis on how mechanistic precision can guide clinical innovation. Conclusions: Here I highlight that neurogenic potential is not entirely lost with age but may be preserved or restored by tuning immune and epigenetic environments. This review proposes a roadmap for reshaping the aging brain’s fate, offering mechanistically grounded strategies to delay cognitive decline. Beyond neurology, the work underscores a broader principle: by integrating cellular plasticity with immune modulation, science edges closer to re-engineering resilience across the lifespan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Neurogenesis–neuroinflammation dynamics across the lifespan. (A) Young: In the healthy young dentate gyrus (DG), abundant and actively cycling neural stem cells generate newborn neurons that successfully mature and integrate into local circuits. Supportive microglia maintain a trophic environment by releasing BDNF and other growth factors, which promote stem-cell activation and neuronal differentiation [26,27,28]. Arrows indicate pro-neurogenic signaling from microglia to stem cells and forward progression from stem cells to newborn neurons. (B) Aged: In the aged DG, stem-cell activation declines and fewer newborn neurons are produced. Microglia adopt reactive phenotypes in response to extrinsic cues (DAMPs, cytokines, peripheral immune signals, metabolic stress, BBB leakage) and intrinsic programs (epigenetic priming/innate immune memory, mitochondrial dysfunction, senescence-linked remodeling), and secrete pro-inflammatory cytokines such as IL-1β that suppress neurogenesis [12,21,24,29,30]. Arrows highlight the shift from supportive trophic signals to inflammatory cues and the resulting reduction in neuronal output. BDNF, brain-derived neurotrophic factor; DG, dentate gyrus; IL-1β, interleukin-1 beta. Created in Biorender. Tanaka, M. (2026) https://BioRender.com/pjz1qcu.](https://figures.cochat.ai/paper-figures/abf923a9c8d4415f9d48212da64cf341/neurogenesis-and-neuroinflammation-in-dialogue-mapping-gaps-modulating-microglia-figure-1.jpg)
![Figure 2 Region-specific microglial diversity and aging. (A) Hippocampus: Hippocampal microglia shift from a predominantly homeostatic profile in young animals to a primed, pro-inflammatory state with aging. This is illustrated by increased reactive microglial signatures and elevated inflammatory markers, reflecting the heightened vulnerability of the neurogenic dentate gyrus (DG). The upward arrow indicates an age-related rise in priming and inflammatory activation [24,29,116]. (B) Cortex: Cortical microglia exhibit a mosaic, transitional aging phenotype. The heatmap summarizes relative transcriptional activities—homeostatic, lipid-associated, interferon-responsive, and DAM (disease-associated microglia) vulnerability—across young and aged states. Color gradients and the horizontal age-arrow illustrate how these signatures shift heterogeneously with age, highlighting multiple partially overlapping microglial subtypes rather than a uniform transition [47,165]. Dark blue—high homeostatic activity; Light blue—moderate homeostatic activity; Grey—lipid-associated activity; Yellow—interferon-responsive activity; Red—high DAM-vulnerability activity (C) Cerebellum: Cerebellar microglia largely preserve a stable, homeostatic phenotype across aging. Bar plots and conceptual illustrations show minimal change in activation markers, and microglia remain predominantly ramified with limited shift toward inflammatory states [166,167]. Overall interpretation: Microglial aging is regionally diverse. Hippocampal microglia tend toward primed, pro-inflammatory profiles; cortical microglia adopt mixed and transitional states; and cerebellar microglia maintain homeostability. This heterogeneity reveals that aging does not uniformly reprogram microglia across the brain and underscores the need for spatially tailored therapeutic strategies targeting region-specific vulnerabilities. DAM, disease-associated microglia. Created in Biorender. Tanaka, M. (2026) https://BioRender.com/vu0jdxr.](https://figures.cochat.ai/paper-figures/b120f3be6e1a4784a68521f8ae27f788/neurogenesis-and-neuroinflammation-in-dialogue-mapping-gaps-modulating-microglia-figure-2.jpg)
![Figure 3 Neuroimmune interventions—from mechanism to therapeutic direction. (A) Imaging: Depicts neuroimmune mapping tools used for diagnostic and analytical purposes. The bullets refer to: Neuroimmune mapping—visualization of microglial and inflammatory states; In vivo monitoring—longitudinal tracking of neurogenic and neuroimmune changes; Functional scans—PET/MRI measures linking immune activity to neurogenic output. These modalities assess, rather than modify, biological pathways [216,217,218]. (B) Immunomodulation: Illustrates strategies that recalibrate maladaptive immune activity. The bullets indicate: Signal tuning—adjusting microglial or cytokine signaling thresholds; Immune recalibration—restoring balanced immune tone; Cytokine control—targeted modulation of IL-1β, TNF, IL-6, or related mediators [24,29]. (C) Glial Reprogramming: Represents approaches that shift glial cell identity or function. Bullets correspond to: Phenotype shift—moving microglia or astrocytes into supportive states; Lineage conversion—direct astrocyte-to-neuron or glia-to-neuron reprogramming; Glial remodeling—restructuring glial networks to enhance neurogenesis [192,219,220]. (D) NLRP3 Inhibition: Highlights suppression of inflammasome-mediated inflammation. Bullets denote: Inflammasome block—direct inhibition of NLRP3 assembly/activation; IL-1β suppression—reduction in downstream pro-inflammatory cytokine release; Danger-signal arrest—prevention of upstream triggers driving chronic activation [221,222,223,224,225,226]. (E) Epigenetic Editing Shows locus-specific chromatin tuning tools. The bullets signify: Chromatin tuning—modifying histone or DNA accessibility at inflammatory loci; Gene correction—targeted suppression or activation of disease-relevant genes; Locus rewriting—durable transcriptional reprogramming without DNA cleavage [227,228,229,230,231,232]. This figure provides a modular overview of five neuroimmune intervention strategies spanning monitoring, immune recalibration, glial engineering, inflammasome blockade, and epigenomic control. Together, they outline mechanistic entry points for preserving or restoring adult neurogenesis. Imaging modalities function strictly as diagnostic and analytical tools rather than interventions, supporting evaluation of therapeutic effects on neurogenic and inflammatory dynamics. IL-1β, interleukin-1 beta; NLPR3, NLR family pyrin domain containing 3. Created in BioRender. Tanaka, M. (2026) https://BioRender.com/073ljub.](https://figures.cochat.ai/paper-figures/7e3e634c4bbf48129ce4ea75de669f75/neurogenesis-and-neuroinflammation-in-dialogue-mapping-gaps-modulating-microglia-figure-3.jpg)
![Figure 4 Comparative overview of neurogenic capacity in rodents and humans. Cross-species comparisons are complicated by age-matching and sampling context: many rodent datasets derive from young adult animals, whereas human evidence often relies on post-mortem tissue from older individuals with variable comorbidity and peri-mortem factors. Accordingly, the schematic emphasizes directional trends and methodological uncertainty, not direct quantitative equivalence of neurogenic ‘capacity’ between species. (A) Rodent Brain: Rodents maintain relatively high levels of adult neurogenesis across the lifespan, supported by diverse microglial populations and sustained subventricular zone (SVZ) neurogenic activity. This includes robust DG and SVZ neurogenesis in young adulthood and measurable persistence into aging, consistent with preclinical neurogenic literature [1,2,3]. Rodent microglia show increased phenotypic diversity and clear age-associated priming [116,165]. Survival curves illustrate the well-documented gradual decline in neuronal persistence with age, while maintaining observable neurogenic capacity. (B) Human Brain: Humans exhibit markedly reduced adult neurogenesis, diminished microglial diversity, and limited or absent SVZ-derived neuronal production. Human studies report much lower baseline neurogenic output, debated persistence in older age groups, and restricted microglial heterogeneity compared with rodents [1,2]. Human microglial transcriptional profiles also show less diverse aging trajectories relative to rodent profiles [304]. The survival curve reflects minimal or near-zero long-term survival of adult-born neurons across adulthood. Translational potential & interventional strategies: The lower panel highlights mechanistic targets and candidate interventions with therapeutic relevance. Inflammasome priming inhibitors: Supported by preclinical NLRP3-blocking agents such as NT-0796, MCC950, BGE-102 [221,222,223,224,226] for longitudinal neuroimmune monitoring: FLT-PET, TSPO-PET, and hybrid PET/MRI [216,217,250]. Exercise-driven neurogenic enhancement: Rodent and translational exercise effects on neurogenesis and inflammatory pathways [301]. Targeted immunopharmacology: Cytokine-level immunomodulation from IL-1β/TNF-driven models [24,29]. Gene-editing platforms: CRISPR-based epigenetic or transcriptional tuning tools [227,229,230,231,232]. SVZ, subventricular zone. Created in BioRender. Tanaka, M. (2026) https://BioRender.com/eqw4kap.](https://figures.cochat.ai/paper-figures/4014198e78a7426782f29ffb9a31f85a/neurogenesis-and-neuroinflammation-in-dialogue-mapping-gaps-modulating-microglia-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the amygdala, neuroinflammatory states raise glutamatergic drive and intrinsic excitability, biasing engram formation toward threat; targeted disinhibition or serotonergic regulation can rebalance excitation and inhibition and restore controlled retrieval of emotional memories [257,397].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [257]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the amygdala, neuroinflammatory states raise glutamatergic drive and intrinsic excitability, biasing engram formation toward threat; targeted disinhibition or serotonergic regulation can rebalance excitation and inhibition and restore controlled retrieval of emotional memories [257,397].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [257]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The Kv7 potassium channel enhancer QO-83, a small-molecule KCNQ/Kv7 channel opener, limits infarct volume, edema, and cognitive decline after ischemic injury while curbing microglial activation, pointing to attenuation of excitotoxic cascades that often follow stress or drug withdrawal [252,255,256,257].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [257]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kuhn, H., Dickinson-Anson, H., & Gage, F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02027.1996 · Cited by 3,139 · cited 3×
“Rodent studies consistently demonstrate that adult neurogenesis undergoes a steep decline with advancing age, marked by reduced progenitor proliferation and a shrinking contribution of new neurons to hippocampal circuits [82,83].”
Reactive astrocyte nomenclature, definitions, and future directions
Escartin, C., Galea, E., Lakatos, A., O’Callaghan, J. P., Petzold, G. C., Serrano-Pozo, A., Steinhäuser, C., Volterra, A., Carmignoto, G., Agarwal, A., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00783-4 · Cited by 2,513 · cited 1×
“Astrocytes are not passive bystanders: with age they enter reactive programs (often described as A1/A2-like, but better viewed as a spectrum of reactive states) that reshape synaptic and stem-cell niches [13,105,106].”
Hammond, T. R., Dufort, C., Dissing-Olesen, L., Giera, S., Young, A., Wysoker, A., Walker, A. J., Segel, M., Nemesh, J., Saunders, A., et al. (2018) · doi:10.1101/406140 · Cited by 2,225 · cited 2×
“Single-cell RNA sequencing across the mouse lifespan uncovers multiple microglial states, with aging marked by heightened chemokine expression and reprogramming of metabolic pathways [165].”
Microglial M1/M2 polarization and metabolic states
Orihuela, R., McPherson, C. A., & Harry, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13139 · Cited by 2,070
Microglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
Sierra, A., Encinas, J. M., Deudero, J. J. P., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., Tsirka, S. E., & Maletic-Savatic, M. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.014 · Cited by 1,622 · cited 1×
“Far from passive sentinels, they actively sculpt the neurogenic niche by phagocytosing apoptotic newborn cells, thereby maintaining homeostasis and determining which neurons survive to maturity [137,138].”
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616 · cited 1×
“Glial subtype reprogramming provides a bold strategy to tackle Gap 1, the challenge of regional microglial diversity, and Gap 2, the influence of inflammasome-driven epigenetic alterations [34].”
Marschallinger, J., Iram, T., Zardeneta, M., Lee, S. E., Lehallier, B., Haney, M. S., Pluvinage, J. V., Mathur, V., Hahn, O., Morgens, D. W., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-019-0566-1 · Cited by 1,586 · cited 6×
“Aged microglia are marked by dystrophic morphology, diminished phagocytic capacity, and transcriptional reprogramming that favors pro-inflammatory gene expression over reparative functions [11,113,114].”
InfluentialMoreno-Jiménez, E. P., Flor-García, M., Terreros-Roncal, J., Rábano, A., Cafini, F., Pallas-Bazarra, N., Ávila, J., & Llorens-Martín, M. (2019) · Nature Medicine · doi:10.1038/s41591-019-0375-9 · Cited by 1,577
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
Marschallinger, J., Iram, T., Zardeneta, M., Lee, S. E., Lehallier, B., Haney, M. S., Pluvinage, J. V., Mathur, V., Hahn, O., Morgens, D. W., et al. (2019) · doi:10.1101/722827 · Cited by 1,414
Research works printed but not linked: 3
- Gemma, 2010, Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain, Aging Dis., 1, 232
- Dutta, 2021, Inferring temporal dynamics from cross-sectional data using Langevin dynamics, R. Soc. Open Sci., 8, 211374, 10.1098/rsos.211374 · DOI
- Kamei, 2022, In vivo Chronic Two-Photon Imaging of Microglia in the Mouse Hippocampus, J. Vis. Exp., 185, e64104
Cited by
Tanaka, M., Araujo, A. C., Valenti, V. E., Guiguer, E. L., Catharin, V. C. S., Gualhardi, C. M., de Souza Bastos Mazuqueli Pereira, E., de Alvares Goulart, R., de Argolo Haber, R. S., de Carvalho, A. C. A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052370 · Cited by 13
Self-citationElucidating the molecular targets in Alzheimer's disease: Advances and therapeutic implications
Soni, U., & Pujari, R. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111660 · Cited by 7
The autophagy-senescence-inflammasome axis: A novel triad in neurodegenerative diseases?
Ellappan, S., Kujur, P. P., & Mondal, A. C. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103248 · Cited by 1
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Self-citationKhan, M. S., Zafar, I., Jamal, A., Bahwerth, F. S., Khan, S., FAIZAN, M., Khan, H., Noman, M., Okeibunor, K., Ahmad, A., et al. (2026) · Acta Neurologica Belgica · doi:10.1007/s13760-026-03033-9 · Cited by 1
Metadata
- Authors
- Tanaka, M.
- Affiliations
- University of Szeged (HU)
- Corresponding author
- Tanaka, Masaru
- ORCID
- Tanaka, Masaru
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2026-01-03
- Volume
- 15
- Issue
- 1
- Pages
- 78
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC12786113
- OpenAlex
- W7118216243
- Cited by
- 11
- References
- 374
- Citations by year
- 2026: 11
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- HUN-REN Hungarian Research Network
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- neurogenesis, neuroinflammation, brain aging, inflammaging, microglia, astrocytes, neural stem cells, microglial heterogeneity, inflammasome signaling, epigenetic regulation, glial reprogramming, immunomodulation, cognitive decline, neurodegeneration, neurogenic niche
- MeSH terms
- Neuroinflammatory Diseases, Aging, Animals, Brain, Humans, Inflammation, Microglia, Neurogenesis, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurogenesis and Neuroinflammation in Dialogue: Mapping Gaps, Modulating Microglia, Rewiring Aging. https://app.cochat.ai/papers/10.3390/cells15010078
- The paper
- Tanaka, M. (2026). Neurogenesis and Neuroinflammation in Dialogue: Mapping Gaps, Modulating Microglia, Rewiring Aging. Cells. https://doi.org/10.3390/cells15010078
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.